Market Access

We develop submissions to Conitec with methodological rigor and complete deliverables, integrating clinical evidence, economic evaluation, and budgetary impact analysis for decisions within the SUS (Brazilian Public Health System).

We support companies and institutions in building consistent contributions and responses, with a clear narrative, scientific backing, and strategic positioning.

We assess the decision context and dossier maturity to guide the next strategic step: submit, strengthen the evidence package, or revise the market access strategy.

We structure dossiers and analyses for submissions to the ANS (Brazilian National Agency for Supplementary Health), with methodological rigor, clarity in the value proposition, and alignment with regulatory deadlines.

We structure CMED price dossiers with technical and documentary consistency, integrating references, comparators, and justifications in accordance with regulations.

We provide comprehensive support throughout submission and technical defense processes, including dossier preparation, technical forms, presentation materials, strategic alignment, and preparation for interactions with decision-making committees.